Shanghai Shen Lian Biomedical Corp
SSE:688098
Relative Value
The Relative Value of one
Shanghai Shen Lian Biomedical Corp
stock under the Base Case scenario is
hidden
CNY.
Compared to the current market price of 9.45 CNY,
Shanghai Shen Lian Biomedical Corp
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
Shanghai Shen Lian Biomedical Corp Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Shanghai Shen Lian Biomedical Corp
SSE:688098
|
3.9B CNY | 13.2 | -85.3 | -63.7 | -63.7 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD | 17.7 | 57 | 38.2 | 41 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
564.7B USD | 6 | 21.1 | 14.7 | 18 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
287.9B CHF | 4.7 | 30.7 | 12.9 | 15.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
294.9B USD | 4.6 | 15.5 | 10.9 | 12.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.6B CHF | 5.3 | 20.5 | 12.9 | 16.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
215B GBP | 5.1 | 31.6 | 15.1 | 22.1 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.3 | 13.1 | 9.2 | 10.6 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.2B USD | 2.4 | 15.6 | 7.8 | 10.7 | |
| FR |
|
Sanofi SA
PAR:SAN
|
98.9B EUR | 1.8 | 8.3 | 7.7 | 7.7 |